Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 8.34 | N/A |
| PEG Ratio (TTM) | -3.38 | N/A |
| P/S Ratio (TTM) | 0.69 | N/A |
| P/B Ratio (TTM) | 2.32 | N/A |
| P/FCF Ratio (TTM) | 7.07 | N/A |
| Price to 5YR AVG Earnings Ratio | 9.32 | N/A |
| Price to 5YR AVG FCF Ratio | 6.01 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 9.69% | N/A |
| ROE (TTM) | 27.71% | N/A |
| Net Profit Margin (TTM) | 8.11% | N/A |
| ROIC 5YR AVG | 20.63% | N/A |
Growth (72%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 21.26% | 50.32% | 26.07% |
| Revenue | 1.29% | 0.95% | -2.66% |
| Net Income | 20.11% | 48.26% | 22.27% |
| Cash Flow | 2,437.30% | 2.18% | 87.66% |
Health (77%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.21 | N/A |
| Quick Ratio (TTM) | 0.96 | N/A |
| D/E Ratio (TTM) | 0.60 | N/A |
| Interest Coverage (TTM) | 9.53 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 3.21 | N/A |
| LTL to 5YR AVG FCF | 2.90 | N/A |
| Shares Outstanding Growth 5YR AVG | -4.50% | N/A |